http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011071404-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3308a28e7f19ac50f7c9cfdf3a976e93 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8c0ee449e8f3f1a728acb5336c420370 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_21b9da2867623acac29e0f85c9f429b8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fbd5f053c57c23ce7973b498c8e3c9bc http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ae2f01bd177015ce710ff1e720e27a95 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_41765b04e324ead7a905c218e2eccf2c |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0003 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| filingDate | 2009-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48f5cb2ab67d4236e4ccda8c61bed4ea http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a23f028197e4c9c24d036975540175d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_486d3d73c0a4fd135e6791eabe0becb4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9cbea87a62a99d27f5919925730e9531 |
| publicationDate | 2011-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2011071404-A1 |
| titleOfInvention | Immunogens, compositions and uses thereof, method for preparing same |
| abstract | The invention relates to fusion proteins comprising an amino acid sequence of a fragment H corresponding to a fragment of a calcium binding protein excreted-secreted by adult worms of Fasciola hepatica , followed by an amino acid sequence corresponding to a unrelated protein or fragment of protein, pharmaceutical compositions, vaccines and adjuvants containing the immunogen, to a process for their preparation, another process for the production of antibodies and their use. The present invention relates to the preparation of immunogens by the addition of a peptide sequence. Thus the present invention is useful for producing an immune response, with increases in specific antibody titers in serum against proteins or other antigens and can be applied in particular for the production of specific polyclonal antibodies, in immunotherapy and immunoprophylaxis. The addition of the polypeptide to a target antigen, either through the production of recombinant proteins containing the polypeptide or by addition or fusion of this polypeptide with the target antigen, induces a significant increase in the immunogenicity of these molecules, amplifying the immune response elicited by injection of this molecule in a species capable of producing antibodies. |
| priorityDate | 2009-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 166.